LUMIVATAMIG
UNII NLU8FTP8AP

Substance Identification & Data

This profile provides standardized clinical and technical data for Lumivatamig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) NLU8FTP8AP.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3035406-55-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
NLU8FTP8AP
CAS Registry Number
3035406-55-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
LUMIVATAMIG
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C224762
National Cancer Institute reference terminology for clinical and research data.
INN ID
13593
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lumivatamig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LUMIVATAMIG

Common Names & Synonyms

IMMUNOGLOBULIN (H-GAMMA1_L-KAPPA)_(H-GAMMA1-17MER-SCFVLH_L-KAPPA), ANTI-(HOMO SAPIENS CLDN18 (CLAUDIN 18, CLAUDIN-18, SURFACTANT ASSOCIATED PROTEIN J, SFTPJ) ISOFORM 2), ANTI-(HOMO SAPIENS CD3D (CD3 DELTA) AND CD3E (CD3 EPSILON, LEU-4) DIMER), HUMANIZED AND CHIMERIC MONOCLONAL ANTIBODY, BISPECIFIC, TRIVALENT (LUMIVATAMIG)
LUMIVATAMIG [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus